13F-HR filed by Commodore Capital LP
Commodore Capital LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 31 holding rows worth $1,364,557,313.
- Accession
- 0001831942-25-000002
- Filer
- CIK 1831942
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 31 entries on the cover page, a total value of $1,364,557,313 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,364,557,313 with VALUE read as dollars as filed, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MERUS N V | N5749R100 | COM | 3,874,182 | $162,909,353 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 1,625,000 | $133,022,500 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 1,621,600 | $126,938,848 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 2,740,000 | $107,408,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 4,205,000 | $94,612,500 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 1,958,600 | $82,829,194 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 1,525,000 | $68,548,750 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 2,300,000 | $66,148,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 3,000,000 | $56,520,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 6,881,629 | $53,676,706 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 1,988,084 | $46,282,596 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 2,400,000 | $46,008,000 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 950,000 | $41,059,000 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 2,218,425 | $37,158,619 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 1,911,433 | $36,642,171 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 4,308,425 | $29,986,638 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 1,419,714 | $27,528,254 | dollars as filed | |
| CARDIFF ONCOLOGY INC | 14147L108 | COM | 5,384,616 | $23,369,233 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 5,925,000 | $19,256,250 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 800,000 | $18,288,000 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 500,000 | $18,010,000 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 2,000,000 | $16,140,000 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 290,000 | $13,137,000 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 1,284,110 | $9,399,685 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 750,000 | $7,635,000 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 500,000 | $5,250,000 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 400,000 | $5,236,000 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 1,575,000 | $4,646,250 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 483,000 | $3,588,690 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 237,704 | $2,445,974 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 351,848 | $876,102 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001831942-25-000002 | this filing | 2025-02-14 | acceptance time not in the bulk data set |